Press Release
Pheonix Research Publishes 2026 “Global C-Reactive Protein (CRP) Assays for Research Use Market Outlook – Press Release”
Global C-Reactive Protein (CRP) Assays for Research Use Market to Reach USD 1.86 Billion by 2033 Amid Rising Biomarker Research, Precision Medicine & High-Sensitivity Immunoassay Innovation
June 2026 | Pheonix Market Research
The Global C-Reactive Protein (CRP) Assays for Research Use Market is projected to grow from USD 0.92 Billion in 2025 to approximately USD 1.86 Billion by 2033, registering a CAGR of 9.20% during the forecast period of 2026–2033, according to the latest market intelligence report published by Pheonix Market Research.
The market is witnessing steady growth driven by increasing biomedical research activities, rising demand for inflammatory biomarkers, expanding investments in life sciences, and growing applications of CRP assays across cardiovascular disease, autoimmune disorders, infectious diseases, oncology, and translational medicine research. Research institutions and biotechnology companies are increasingly utilizing advanced CRP assay technologies to improve biomarker discovery, disease characterization, and therapeutic development.
The industry is also benefiting from rapid advancements in immunoassay technologies, laboratory automation, multiplex biomarker analysis, and high-sensitivity detection platforms. Increasing adoption of high-sensitivity CRP (hs-CRP) assays, automated laboratory workflows, and integrated bioinformatics tools is enabling researchers to generate more accurate and reproducible data. In addition, expanding precision medicine initiatives and increasing pharmaceutical research investments continue to accelerate demand for research-use-only (RUO) CRP assay solutions worldwide.
According to Pheonix Market Research, continued growth in biomarker discovery, expanding translational research programs, and technological innovation in immunoassay platforms are expected to create significant opportunities throughout the forecast period.
Asia-Pacific is anticipated to emerge as the fastest-growing regional market due to increasing biotechnology investments, expanding academic research infrastructure, and rising pharmaceutical R&D activities. North America continues to dominate the global market owing to its well-established life sciences ecosystem, substantial research funding, advanced laboratory technologies, and strong presence of leading biotechnology and pharmaceutical companies.
A Senior Healthcare & Life Sciences Analyst at Pheonix Market Research stated:
“C-reactive protein assays continue to play a vital role in inflammation research and biomarker discovery. As precision medicine and translational research expand globally, high-sensitivity assay technologies, laboratory automation, and multiplex immunoassays will become increasingly important for improving research efficiency and accelerating scientific innovation across life sciences.”
Key Market Highlights
- ELISA-Based CRP Assays remain the largest segment due to their widespread adoption in biomarker and academic research.
- High-Sensitivity CRP (hs-CRP) Research Assays are the fastest-growing segment driven by cardiovascular and chronic inflammation research.
- Academic & Research Institutes continue to represent the leading end-use segment globally.
- Precision medicine initiatives are accelerating demand for advanced inflammatory biomarker analysis.
- Multiplex immunoassays and automated laboratory platforms are improving research efficiency and analytical accuracy.
- Pharmaceutical and biotechnology R&D investments are supporting broader adoption of research-grade CRP assay technologies.
- Research Use Only (RUO) labeling regulations, laboratory quality standards, and biomedical research compliance continue to influence market development.
Report Highlights
- Market Size (2025): USD 0.92 Billion
- Market Size (2033): USD 1.86 Billion
- CAGR (2026–2033): 9.20%
- Largest Segment: ELISA-Based CRP Assays
- Fastest Growing Segment: High-Sensitivity CRP (hs-CRP) Research Assays
- Leading End-Use Segment: Academic & Research Institutes
- Key Trend: High-Sensitivity Biomarker Analysis, Multiplex Immunoassays & Automated Laboratory Platforms
About Pheonix Market Research
Pheonix Market Research is a global market intelligence and strategic advisory firm specializing in healthcare, biotechnology, life sciences, diagnostics, pharmaceuticals, and emerging technology markets. The firm provides data-driven insights, market forecasting, competitive intelligence, and strategic recommendations that enable businesses, investors, and policymakers to make informed decisions in rapidly evolving industries.
📊 For detailed insights and full report access:
Website: https://www.pheonixresearch.com/healthcare/healthcare-pharmaceuticals/market-report/global-c-reactive-protein-crp-assays-for-research-use-market/
Media Contact
Pheonix Market Research
Email: [email protected]
Website: www.pheonixmarketresearch.com